China Medicine Corporation
Simbols: CHME
PNK
0.028
USDTirgus cena šodien
0.0009
P/E koeficients
-0.0001
PEG koeficients
79.67M
MRK Cap
- 0.00%
DIV ienesīgums
China Medicine Corporation (CHME) Finanšu pārskati
Bilance
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.5 | 2.8 | 5.8 | ||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.net-receivables | 0 | 22.3 | 19.8 | 13.6 | ||||||
balance-sheet.row.inventory | 0 | 2.7 | 4.7 | 3.9 | ||||||
balance-sheet.row.other-current-assets | 0 | 0.5 | 6.3 | 6.1 | ||||||
balance-sheet.row.total-current-assets | 0 | 30.3 | 33.7 | 29.4 | ||||||
balance-sheet.row.property-plant-equipment-net | 0 | 12 | 3.8 | 1.4 | ||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.intangible-assets | 0 | 16.7 | 1.2 | 1.2 | ||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 16.7 | 1.2 | 1.2 | ||||||
balance-sheet.row.long-term-investments | 0 | 7.9 | 0 | 0 | ||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 6 | 0.7 | ||||||
balance-sheet.row.total-non-current-assets | 0 | 36.6 | 11 | 3.2 | ||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-assets | 0 | 66.8 | 44.7 | 32.6 | ||||||
balance-sheet.row.account-payables | 0 | 1.3 | 0.1 | 0 | ||||||
balance-sheet.row.short-term-debt | 0 | 9.5 | 0 | 0 | ||||||
balance-sheet.row.tax-payables | 0 | 2.1 | 0.8 | 0 | ||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||
balance-sheet.row.other-current-liab | 0 | 0.5 | 1 | 0.9 | ||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6.9 | 0 | 0 | ||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-liab | 0 | 21.3 | 1.1 | 0.9 | ||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.retained-earnings | 0 | 22.9 | 22.1 | 14 | ||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 4.4 | 4.4 | 4.3 | ||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 17.7 | 16.2 | 12.6 | ||||||
balance-sheet.row.total-stockholders-equity | 0 | 45 | 42.8 | 30.9 | ||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 66.8 | 44.7 | 32.6 | ||||||
balance-sheet.row.minority-interest | 0 | 0.5 | 0.8 | 0.9 | ||||||
balance-sheet.row.total-equity | 0 | 45.5 | 43.6 | 31.8 | ||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||
Total Investments | 0 | 7.9 | 0 | 0 | ||||||
balance-sheet.row.total-debt | 0 | 9.5 | 0 | 0 | ||||||
balance-sheet.row.net-debt | 0 | 9 | -2.8 | -5.8 |
Naudas plūsmas pārskats
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1.4 | 9.1 | 6.9 | ||||||
cash-flows.row.depreciation-and-amortization | 0 | 1 | 0.4 | 0.8 | ||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.stock-based-compensation | 0 | 0.1 | 0.1 | 0 | ||||||
cash-flows.row.change-in-working-capital | 0 | 7.1 | -5.4 | -10.1 | ||||||
cash-flows.row.account-receivables | 0 | -2.3 | -4.8 | 0 | ||||||
cash-flows.row.inventory | 0 | 3.4 | -0.5 | -1.8 | ||||||
cash-flows.row.account-payables | 0 | 0.6 | 0 | 0 | ||||||
cash-flows.row.other-working-capital | 0 | 5.4 | -0.1 | -8.2 | ||||||
cash-flows.row.other-non-cash-items | 0 | 7.3 | -0.1 | 0.1 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -3.7 | -2.7 | -0.4 | ||||||
cash-flows.row.acquisitions-net | 0 | -8 | 0 | 0 | ||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -5.2 | 0 | ||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.other-investing-activites | 0 | -1.9 | 0 | 0 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -13.5 | -7.9 | -0.4 | ||||||
cash-flows.row.debt-repayment | 0 | -10.6 | 0 | 0 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 7.8 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.other-financing-activites | 0 | 4.9 | 0.4 | 0 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -5.7 | 0.4 | 7.8 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0.3 | 0.3 | ||||||
cash-flows.row.net-change-in-cash | 0 | -2.3 | -3 | 5.4 | ||||||
cash-flows.row.cash-at-end-of-period | 0 | 0.5 | 2.8 | 5.8 | ||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2.8 | 5.8 | 0.4 | ||||||
cash-flows.row.operating-cash-flow | 0 | 17 | 4.2 | -2.3 | ||||||
cash-flows.row.capital-expenditure | 0 | -3.7 | -2.7 | -0.4 | ||||||
cash-flows.row.free-cash-flow | 0 | 13.3 | 1.5 | -2.7 |
Peļņas vai zaudējumu aprēķina rinda
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 64.8 | 53.6 | 42.1 | ||||||
income-statement-row.row.cost-of-revenue | 0 | 45.8 | 38.1 | 29.7 | ||||||
income-statement-row.row.gross-profit | 0 | 19 | 15.6 | 12.4 | ||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.operating-expenses | 0 | 6.7 | 4.6 | 4 | ||||||
income-statement-row.row.cost-and-expenses | 0 | 52.5 | 42.7 | 33.7 | ||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||
income-statement-row.row.total-other-income-expensenet | 0 | -7.3 | 0.1 | 0 | ||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.total-operating-expenses | 0 | -7.3 | 0.1 | 0 | ||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1 | 0.4 | 0.8 | ||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||
income-statement-row.row.operating-income | 0 | 12.3 | 10.9 | 8.4 | ||||||
income-statement-row.row.income-before-tax | 0 | 5 | 11 | 8.4 | ||||||
income-statement-row.row.income-tax-expense | 0 | 3.5 | 2 | 1.6 | ||||||
income-statement-row.row.net-income | 0 | 1.7 | 9.1 | 6.9 |
Biežāk uzdotie jautājumi
Kas ir China Medicine Corporation (CHME) kopējie aktīvi?
China Medicine Corporation (CHME) kopējie aktīvi ir 66844482.000.
Kādi ir uzņēmuma gada ieņēmumi?
Gada ieņēmumi ir N/A.
Kāda ir uzņēmuma peļņas norma?
Uzņēmuma peļņas norma ir 0.293.
Kāda ir uzņēmuma brīvā naudas plūsma?
Brīvā naudas plūsma ir 0.870.
Kāda ir uzņēmuma neto peļņas norma?
Neto peļņas norma ir 0.027.
Kādi ir uzņēmuma kopējie ieņēmumi?
Kopējie ieņēmumi ir 0.189.
Kāda ir China Medicine Corporation (CHME) tīrā peļņa (tīrie ienākumi)?
Tīrā peļņa (tīrie ienākumi) ir 1717677.000.
Kāds ir uzņēmuma kopējais parāds?
Kopējais parāds ir 9506160.000.
Kāds ir pamatdarbības izdevumu skaits?
Darbības izdevumi ir 6718099.000.
Kāds ir uzņēmuma skaidrās naudas rādītājs?
Uzņēmuma nauda ir 0.000.